Faculty Opinions recommendation of Clinical effectiveness and safety of erythropoietin-stimulating agents for the treatment of low- and intermediate-1-risk myelodysplastic syndrome: a systematic literature review.
2018 ◽
Vol 184
(2)
◽
pp. 134-160
◽
2019 ◽
Vol 12
(3)
◽
pp. 280-295
◽
2018 ◽
Vol 19
(4)
◽
pp. 600-611
◽